- Previous Close
25.56 - Open
25.47 - Bid 25.39 x 900
- Ask 25.41 x 1000
- Day's Range
24.94 - 26.06 - 52 Week Range
17.07 - 30.53 - Volume
279,831 - Avg. Volume
460,318 - Market Cap (intraday)
1.496B - Beta (5Y Monthly) 1.03
- PE Ratio (TTM)
-- - EPS (TTM)
-1.02 - Earnings Date May 28, 2025 - Jun 2, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
32.31
Phreesia, Inc. engages in the provision of an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers an appointment scheduling system for online appointments, reminders, and referral tracking and management; registration solutions to automate patient self-registration; revenue cycle solutions that provide insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. It deploys its platform in a range of modalities, including Phreesia Mobile, a patients' mobile device; PhreesiaPads, a self-service intake tablets; Phreesia Dashboard, a web-based dashboard for healthcare services clients; and Arrivals Kiosks, which are on-site kiosks. The company serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.
www.phreesia.com2,082
Full Time Employees
January 31
Fiscal Year Ends
Sector
Industry
Recent News: PHR
View MorePerformance Overview: PHR
Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PHR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PHR
View MoreValuation Measures
Market Cap
1.50B
Enterprise Value
1.44B
Trailing P/E
--
Forward P/E
90.91
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.51
Price/Book (mrq)
5.67
Enterprise Value/Revenue
3.42
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-13.94%
Return on Assets (ttm)
-8.75%
Return on Equity (ttm)
-22.67%
Revenue (ttm)
419.81M
Net Income Avi to Common (ttm)
-58.53M
Diluted EPS (ttm)
-1.02
Balance Sheet and Cash Flow
Total Cash (mrq)
439.85M
Total Debt/Equity (mrq)
2.60%
Levered Free Cash Flow (ttm)
28.64M